MIR Stock - Mirion Technologies, Inc.
Unlock GoAI Insights for MIR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $860.80M | $800.90M | $717.80M | $668.30M | N/A |
| Gross Profit | $401.80M | $356.50M | $317.20M | $284.20M | N/A |
| Gross Margin | 46.7% | 44.5% | 44.2% | 42.5% | N/A |
| Operating Income | $24.80M | $-21,900,000 | $-297,800,000 | $-68,700,000 | $-2,449,094 |
| Net Income | $-36,100,000 | $-96,900,000 | $-276,900,000 | $-222,500,000 | $-45,255,407 |
| Net Margin | -4.2% | -12.1% | -38.6% | -33.3% | N/A |
| EPS | $-0.18 | $-0.49 | $-1.53 | $-0.61 | $-0.48 |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 25th 2025 | Evercore ISI | Initiation | Outperform | $29 |
| September 26th 2025 | JP Morgan | Initiation | Overweight | $28 |
| August 25th 2025 | Northland Capital | Initiation | Outperform | $26 |
| December 19th 2024 | Robert W. Baird | Initiation | Outperform | $22 |
| September 26th 2024 | B. Riley Securities | Initiation | Buy | $14 |
| May 26th 2023 | Citigroup | Resumed | Buy | $11 |
Earnings History & Surprises
MIREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | $0.17 | — | — | — |
Q4 2025 | Oct 28, 2025 | $0.11 | $0.12 | +9.1% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $0.10 | $0.11 | +10.0% | ✓ BEAT |
Q2 2025 | Apr 29, 2025 | $0.10 | $0.10 | 0.0% | = MET |
Q1 2025 | Feb 11, 2025 | $0.14 | $0.17 | +21.4% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $0.11 | $0.08 | -27.3% | ✗ MISS |
Q3 2024 | Aug 1, 2024 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $0.06 | $0.06 | 0.0% | = MET |
Q1 2024 | Feb 13, 2024 | $0.14 | $0.15 | +7.1% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $0.05 | $0.05 | 0.0% | = MET |
Q3 2023 | Aug 2, 2023 | $0.06 | $0.08 | +33.3% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $0.12 | $0.11 | -8.3% | ✗ MISS |
Q4 2022 | Nov 1, 2022 | $0.06 | $0.03 | -50.0% | ✗ MISS |
Q3 2022 | Jul 29, 2022 | $0.12 | $0.13 | +8.3% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $0.09 | $0.10 | +11.1% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.12 | $-0.56 | -567.2% | ✗ MISS |
Q4 2021 | Nov 12, 2021 | — | $-3.02 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-8.14 | — | — |
Latest News
Citigroup Maintains Buy on Mirion Technologies, Lowers Price Target to $33
📈 PositiveEvercore ISI Group Initiates Coverage On Mirion Technologies with Outperform Rating, Announces Price Target of $29
📈 PositiveCitigroup Maintains Buy on Mirion Technologies, Raises Price Target to $35
📈 PositiveJP Morgan Maintains Overweight on Mirion Technologies, Raises Price Target to $34
📈 PositiveMirion Technologies Affirms FY2025 Adj EPS Guidance of $0.48-$0.52 vs $0.48 Est; Affirms FY2025 Sales Guidance of $921.056M-$938.272M vs $921.660M Est
📈 PositiveMirion Technologies Q3 Adj. EPS $0.12 Beats $0.10 Estimate, Sales $223.100M Beat $222.155M Estimate
📈 PositiveCitigroup Maintains Buy on Mirion Technologies, Raises Price Target to $28
📈 PositiveNorthland Capital Markets Maintains Outperform on Mirion Technologies, Raises Price Target to $29
📈 PositiveBaird Maintains Outperform on Mirion Technologies, Raises Price Target to $26
📈 PositiveJP Morgan Initiates Coverage On Mirion Technologies with Overweight Rating, Announces Price Target of $28
📈 PositiveMirion Technologies Upsizes Convertible Senior Notes Offering To $325.0M With Maturity October 1 2031 And 0.00% Interest
📈 PositiveMirion Technologies Prices $350M Upsizes Public Offering Of 17,309,846 Class A Common Shares At $21.35 Each
➖ NeutralMirion Technologies shares are trading lower after the company announced a $250 million offering of Convertible Senior Notes Due 2031. Also, the company announced a $350 million offering of Class A common stock.
📉 NegativeMirion Technologies Launches $350M Public Offering Of Class A Common Stock
➖ NeutralMirion Technologies Reveals Proposed $250.0M Offering of Convertible Senior Notes Due 2031
➖ NeutralMirion Technologies shares are trading lower after the company announced it entered into a definitive agreement to acquire Paragon Energy Solutions from Windjammer Capital Investors for approximately $585 million. Also, the company cut its FY25 organic revenue growth guidance.
📉 NegativeMirion Now Expects FY25 Organic Revenue Growth To Be ~4.5% - 6.0% Versus Prior Target Range Of 5.0% - 7.0%
📉 NegativeMirion's Paragon Energy Deal Expected To Be EPS Accretive And Generate $10M Synergies By Year Five
📈 PositiveMirion Agrees To Acquire Paragon Energy Solutions From Windjammer Capital Investors For ~$585M In Cash
➖ NeutralMirion Technologies Signs A Partnership Agreement And Practical Arrangements With The International Atomic Energy Agency To Cooperate In The Area Of Radiation Detection And Measurement
📈 PositiveFrequently Asked Questions about MIR
What is MIR's current stock price?
What is the analyst price target for MIR?
What sector is Mirion Technologies, Inc. in?
What is MIR's market cap?
Does MIR pay dividends?
Similar Stocks
Industrials SectorExplore stocks similar to MIR for comparison